Perioperative Aminophylline to Improve Early Kidney Function After a Kidney Transplant

Trial ID or NCT#

NCT01759862

Status

not recruiting iconNOT RECRUITING

Purpose

The aim of this study is to evaluate whether peri-transplant administration of a drug named aminophylline to children undergoing a kidney transplant from deceased donors improves early graft function and also projects on long term graft function.

Official Title

Perioperative Aminophylline to Improve High Risk Renal Graft Outcome- a Double Blinded, Placebo Controlled, Randomized Clinical Trial

Eligibility Criteria

Ages Eligible for Study: 1 Year to 21 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. 1. Pediatric kidney transplant recipients less than 21 years of age2. Patients undergoing deceased donor (DD) kidney transplants
Exclusion Criteria:
  1. 1. Known history of non-sinus tachycardia2. Multiple organ transplants recipients3. Severe liver dysfunction4. graft was placed on pump after harvesting
View All Criteria
Show Less

Investigator(s)

Paul C. Grimm

Contact us to find out if this trial is right for you.

Contact

Vivian Shih, MD
650-723-7903

View on ClinicalTrials.gov